MENU
NRIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nurix Therapeutics (NRIX) Earnings Date & Reports
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases... Show more
A.I. Advisor
published Earnings
NRIX is expected to report earnings to fall 101.82% to -8 cents per share on February 17
Q4'26
Est.
$-0.09
Q3'26
Beat
by $5.34
Q2'26
Missed
by $0.09
Q1'26
Missed
by $0.03
Q4'25
Beat
by $0.10
The last earnings report on October 12 showed earnings per share of $4.73, beating the estimate of -61 cents. With 1.64M shares outstanding, the current market capitalization sits at 2.46B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders
Industry Biotechnology
Industry
N/A
Address
1600 Sierra Point Parkway
Phone
+1 415 660-5320
Employees
317
Web
https://www.nurixtx.com